Logotype for Schrödinger Inc

Schrödinger (SDGR) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Schrödinger Inc

Q3 2026 earnings summary

6 Nov, 2026

Executive summary

  • Q3 revenue rose 19% YoY to $64.5M; ACV was $44.7M, up 17%, or 24% excluding contribution ACV. FY26 ACV and drug discovery revenue guidance increased.

  • Hosted adoption and a Structure Therapeutics milestone supported results; operating loss narrowed, while the net loss widened on equity-investment fair-value losses.

Financial highlights

  • Q3 total revenue was $64.5M versus $54.3M; gross profit was $38.3M versus $28.0M, and operating loss was $26.1M versus $45.9M.

  • Operating expenses were $64.4M, down 13% YoY; net loss was $37.7M versus $32.8M, with diluted loss per share of $0.50 versus $0.45.

  • Other expense included a $14.8M fair-value loss on equity investments; contribution revenue declined 60% to $2.1M as initial predictive-toxicology grant funding was completed.

  • 9M revenue was $182.0M versus $168.6M; net loss narrowed to $91.8M from $135.8M.

Outlook and guidance

  • FY26 ACV guidance increased to $222M–$232M, implying 12%–17% growth over 2025; drug discovery revenue guidance rose to $75M–$85M from $65M–$75M.

  • FY26 operating expenses are expected below 2025; existing cash and securities are expected to cover operating and capital needs for at least 24 months.

  • Hosted-software transitions shift revenue recognition over contract terms and may contribute to near-term revenue declines.

  • 2028 objectives include 10%–15% annual ACV growth, gross margin returning to the high 70s, $50M annual drug discovery revenue, and positive adjusted EBITDA by year-end.

  • Full commercial release of Bunsen was expected by year-end 2026; predictive toxicology capabilities were being made more broadly available during 2026.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Schrödinger